Cellular Goods is running the outdoor digital campaign for the next two months.
The appeal states there is an urgent need to address serious governance and sclerotic management issues.
Oxford Cannabinoid Technologies has stated it will begin Phase I clinical trials early next year.
CBG has anti-inflammatory and antioxidant properties.
A public consultation has now been launched on the science innovation and research centre that will be established by Peel NRE.
Pharma titan Pfizer is to acquire Arena Pharmaceuticals which has a pipeline in cannabinoid therapeutics.
2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
The global cannabinoid pharmaceuticals market has been projected to reach £1.53bn (€1.8bn).
American cannabinoid manufacturer and supplier is expanding to supply the European market.
Piauhy Labs will study the efficacy of cannabinoids for the treatment of diseases such as autism, epilepsy and Alzheimer’s.
